Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss

Diabetes. 2014 Jun;63(6):1860-9. doi: 10.2337/db13-1546. Epub 2014 Jan 23.

Abstract

Shift workers, who are exposed to irregular sleep schedules resulting in sleep deprivation and misalignment of circadian rhythms, have an increased risk of diabetes relative to day workers. In healthy adults, sleep restriction without circadian misalignment promotes insulin resistance. To determine whether the misalignment of circadian rhythms that typically occurs in shift work involves intrinsic adverse metabolic effects independently of sleep loss, a parallel group design was used to study 26 healthy adults. Both interventions involved 3 inpatient days with 10-h bedtimes, followed by 8 inpatient days of sleep restriction to 5 h with fixed nocturnal bedtimes (circadian alignment) or with bedtimes delayed by 8.5 h on 4 of the 8 days (circadian misalignment). Daily total sleep time (SD) during the intervention was nearly identical in the aligned and misaligned conditions (4 h 48 min [5 min] vs. 4 h 45 min [6 min]). In both groups, insulin sensitivity (SI) significantly decreased after sleep restriction, without a compensatory increase in insulin secretion, and inflammation increased. In male participants exposed to circadian misalignment, the reduction in SI and the increase in inflammation both doubled compared with those who maintained regular nocturnal bedtimes. Circadian misalignment that occurs in shift work may increase diabetes risk and inflammation, independently of sleep loss.

Trial registration: ClinicalTrials.gov NCT00989534.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / metabolism
  • C-Reactive Protein / metabolism
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / prevention & control
  • Chronobiology Disorders / complications
  • Chronobiology Disorders / metabolism*
  • Chronobiology Disorders / physiopathology
  • Circadian Rhythm / physiology*
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / metabolism*
  • Diabetes Mellitus, Type 2 / prevention & control
  • Female
  • Humans
  • Inflammation / metabolism
  • Insulin / metabolism
  • Insulin Resistance*
  • Male
  • Occupational Diseases / complications
  • Occupational Diseases / metabolism*
  • Occupational Diseases / physiopathology
  • Prediabetic State
  • Prospective Studies
  • Sleep
  • Sleep Deprivation / complications
  • Sleep Deprivation / metabolism*
  • Wakefulness

Substances

  • Biomarkers
  • Insulin
  • C-Reactive Protein

Associated data

  • ClinicalTrials.gov/NCT00989534